Navigation Links
Novel protein found to enhance effect of Vitamin E and suppress prostate cancer

Researchers have identified a protein that disrupts an important signaling pathway in prostate cancer cells, thereby suppressing the tumor. The protein also enhances the retention of Vitamin E // that limits the proliferation of cancer cells.

The researchers of the present study are the first to describe the role of a protein known as alpha tocopherol associated protein or TAP in prostate cancer. Expression levels of TAP are significantly lower in prostate cancer than in a normal prostate.

Restoration of the levels of the protein in individuals with prostate cancer can be extended to have a therapeutic effect. The approach however would be technically very difficult. Therefore, the present practical solution is to investigate whether specific substances can increase the expression of TAP.

TAP is a binding protein that performs important cellular functions. The high levels of TAP in normal prostate cells suggest that TAP facilitates the transport of vitamin E into prostate tissue and helps retain high concentrations of the vitamin in the cells.

In prostate cancer cells, the researchers showed for the first time that TAP supports the retention of vitamin E. It was also found that TAP increases vitamin E's capacity to control the rapid growth of the cancer cells.

A cell can send messages from its surface to the nucleus through a set of chemical reactions known as a signaling pathway. The disruption of such a pathway by TAP has been found to suppress cancer cell growth. The pathway involves two proteins, phosphatidylinositol 3-kinase and constitutively active Akt, both of which play an important role in the initiation and progression of prostate cancer.

If research continues to show the important role of TAP, we could use TAP expression levels to better assess and predict the aggressiveness of the cancer. We may even be able to use TAP levels to predict whether a patient will respond to treatment.


'"/>




Page: 1

Related medicine news :

1. Novel "CYCLOSPORINE CAPSULE FORMULATION" to be launched
2. Novel biopsy technique for prostate cancer
3. Novel computer model for breast cancer
4. Novel research on liver cancer
5. Novel way to fight cancer
6. Novel test for bowel cancer
7. Novel Anti-Neutrophilic Effect produced by Salmeterol in mild asthma patients
8. Novel Therapy for Chronic Problem
9. Blood Sugar Kept In Control By Novel Protein
10. Novel antibiotic dressing developed for improved wound healing
11. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/28/2017)... ... ... Isabella Wentz, PharmD, FASCP, one of the leading thyroid experts of the world, is ... about journey and research recently on a blog and discussed some major aspects of ... deal with thyroid disease. , Dr. Wentz completed her graduation from the Midwestern ...
(Date:3/28/2017)... ... March 28, 2017 , ... Alert Sentry Group LLC., a leader ... Emergency Response Systems), the iSAFE and the iSAFE Plus. These iSAFE products are the ... their kind, the iSAFE and iSAFE Plus offer direct GPS Location and two-way calling ...
(Date:3/28/2017)... ... 28, 2017 , ... Calibration, qualification, and the appropriate level ... maintaining GMP and USP compliance. In a new webinar from METTLER TOLEDO entitled ... these requirements are explained. The challenge is to determine how to put ...
(Date:3/28/2017)... ... March 28, 2017 , ... METTLER ... ions found in power plant water and steam. , Chlorides and sulfates cause ... boilers, leading to extensive maintenance and unplanned shutdowns. Monitoring these ions at low ...
(Date:3/28/2017)... ... March 28, 2017 , ... AutismOne announced the Board Certified ... Integrative Medicine and available for application on Saturday, May 27, 2017, following Thursday, ... Colorado Springs. , Ed Arranga, president of AutismOne, stated: "Many of the modalities ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... -- Akcea Therapeutics, a subsidiary of Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), ... Christopher Gabrieli , partner ... chairman of the board of Akcea Therapeutics. ... Laboratories. Sandford D. Smith , founder ... "We are excited to announce this expansion to our board ...
(Date:3/28/2017)... ROCKVILLE, Md. , March 28, 2017 /PRNewswire/ ... dedicated to innovative therapeutics addressing cancer and other ... at the American Association for Cancer Research annual ... April 3 is entitled "Evaluation of ENMD-2076 ... and the second poster to be presented ...
(Date:3/28/2017)... 28, 2017 The global ... a value of USD 4.5 billion by 2025, according ... Proper closure of injured tissues post operation is a ... leakages occur in 3% to 15% of cases and ... for one third of postoperative deaths in patients. Surgical ...
Breaking Medicine Technology: